ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,282.70
0.13%
US Tech 100
17,825.60
0.33%
다우존스 지수
39,142.23
-1.33%
Bitcoin
84,581.20
-0.40%
Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ

  6. NAYA Biosciences Inc (NAYA) 시세

NAYA Biosciences Inc

NAYA Biosciences Inc (NAYA)

NASDAQ
1.92
0.08
(4.35%)
마감 18 4월 5:00AM
15분 지연
1.84
-0.08
(-4.17%)
시간외 거래: 8:40AM
15분 지연

포트폴리오 강화: 실시간 토론 및 실행 가능한 거래 아이디어.

프리미엄

주요 통계 및 세부정보

가격
1.84
매수가
1.90
매도가
2.07
거래량
19,320
1.84 일간 변동폭 1.972
1.38 52주 범위 14.16
market_cap
1.226M
전일 종가
1.84
개장가
1.84
최근 거래 시간
125
@
1.84
(formt)
마지막 거래 시간
재정 규모
US$ 37,192
VWAP
1.9251
평균 볼륨(3m)
131,319
발행 주식
666,058
배당수익률
-
주가수익률
-0.16
주당순이익(EPS)
-12.06
매출
3.02M
순이익
-8.04M

NAYA Biosciences Inc 정보

INVO Bioscience Inc operates as a medical device company focused on creating simplified, lower cost treatments for patients diagnosed with infertility. INVO Bioscience Inc operates as a medical device company focused on creating simplified, lower cost treatments for patients diagnosed with infertility.

섹터
Surgical,med Instr,apparatus
산업
Surgical,med Instr,apparatus
웹사이트
www.invobioscience.com
본부
Las Vegas, Nevada, USA
설립됨
-
NAYA Biosciences Inc is listed in the Surgical,med Instr,apparatus sector of the 나스닥 with ticker NAYA. The last closing price for NAYA Biosciences was US$1.84. Over the last year, NAYA Biosciences shares have traded in a share price range of US$ 1.38 to US$ 14.16.

NAYA Biosciences currently has 666,058 shares in issue. The market capitalisation of NAYA Biosciences is US$1.23 million. NAYA Biosciences has a price to earnings ratio (PE ratio) of -0.16.

NAYA 최신 뉴스

추가 뉴스

Form 8-K - Current report
Edgar (US Regulatory)
14 4월 2025
NAYA (4.35%)

Form 8-K - Current report
Edgar (US Regulatory)
01 4월 2025
NAYA (4.35%)

Form 8-K - Current report
Edgar (US Regulatory)
25 3월 2025
NAYA (4.35%)

Form DEFR14A - Revised definitive proxy soliciting materials
Edgar (US Regulatory)
13 3월 2025
NAYA (4.35%)

Form S-8 - Securities to be offered to employees in employee benefit plans
Edgar (US Regulatory)
26 2월 2025
NAYA (4.35%)
기간변동변동 %시가고가저가평균 일일 거래량VWAP
10.15.747126436781.742.331.6035670121.97461738CS
4-0.46-202.32.751.381049412.0451054CS
12-3.632-66.37426900585.4726.00841.381313193.26766932CS
26-10.28-84.818481848212.1214.161.381963278.25149643CS
52-10.28-84.818481848212.1214.161.381963278.25149643CS
156-10.28-84.818481848212.1214.161.381963278.25149643CS
260-10.28-84.818481848212.1214.161.381963278.25149643CS

NAYA - Frequently Asked Questions (FAQ)

What is the current NAYA Biosciences share price?
The current share price of NAYA Biosciences is US$ 1.84
How many NAYA Biosciences shares are in issue?
NAYA Biosciences has 666,058 shares in issue
What is the market cap of NAYA Biosciences?
The market capitalisation of NAYA Biosciences is USD 1.23M
What is the 1 year trading range for NAYA Biosciences share price?
NAYA Biosciences has traded in the range of US$ 1.38 to US$ 14.16 during the past year
What is the PE ratio of NAYA Biosciences?
The price to earnings ratio of NAYA Biosciences is -0.16
What is the cash to sales ratio of NAYA Biosciences?
The cash to sales ratio of NAYA Biosciences is 0.42
What is the reporting currency for NAYA Biosciences?
NAYA Biosciences reports financial results in USD
What is the latest annual turnover for NAYA Biosciences?
The latest annual turnover of NAYA Biosciences is USD 3.02M
What is the latest annual profit for NAYA Biosciences?
The latest annual profit of NAYA Biosciences is USD -8.04M
What is the registered address of NAYA Biosciences?
The registered address for NAYA Biosciences is 187 E WARM SPRINGS ROAD, SUITE B, LAS VEGAS, NEVADA, 89119
What is the NAYA Biosciences website address?
The website address for NAYA Biosciences is www.invobioscience.com
Which industry sector does NAYA Biosciences operate in?
NAYA Biosciences operates in the SURGICAL,MED INSTR,APPARATUS sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
MSGMMotorsport Games Inc
US$ 2.69
(140.18%)
37M
SXTCChina SXT Pharmaceuticals Inc
US$ 2.11
(113.37%)
51.73M
ADGMAdagio Medical Holdings Inc
US$ 1.68
(81.98%)
115.48M
PNBKPatriot National Bancorp Inc
US$ 3.28
(73.54%)
1.57M
RTCBaijiayun Group Ltd
US$ 0.3601
(67.49%)
187.02M
LXEHLixiang Education Holding Company Ltd
US$ 8.25
(-64.11%)
1.55M
CLIKClick Holdings Ltd
US$ 0.355
(-48.18%)
13.52M
IOTRiOThree Ltd
US$ 1.1409
(-38.33%)
3.93M
FMTOFemto Technologies Inc
US$ 0.0191
(-35.47%)
198.4M
SISIShineco Inc
US$ 0.5809
(-35.07%)
824.91k
DMNDamon Inc
US$ 0.0034
(9.68%)
409.39M
STSSSharps Technology Inc
US$ 0.03195
(20.57%)
391.8M
SUNESUNation Energy Inc
US$ 0.0176
(-10.20%)
349.4M
NVDANVIDIA Corporation
US$ 101.49
(-2.87%)
292.48M
HTZHertz Global Holdings Inc
US$ 8.205
(43.70%)
266.91M

토론

전체 피드 보기
Golfbum22 Golfbum22 6 분 전
Layton
Calabria

And many others were bought up by the tbtf banksters long ago

They keep talking to the fake news media to get paid even more

It’s beyond ridiculous

Send doge after these criminals
FMCC
Golfbum22 Golfbum22 10 분 전
Layton
Calabria

And many others were bought up by the tbtf banksters long ago

They keep talking to the fake news media to get paid even more

It’s beyond ridiculous

Send doge after these criminals
FNMA
Baxers Baxers 13 분 전
Utter stupidity IMHO. It's like handing a loaded gun to the people who are actively trying to steal your belongings. On such a heavily shorted biotech stock facing a binary event like MA, your shares are your (only) leverage. Lending them out only empowers the very ruthless pricks trying to profit f
NWBO
BluePuppet BluePuppet 14 분 전
Expert market
GTEH
BluePuppet BluePuppet 14 분 전
Expert market
SVTE
Elcappy1 Elcappy1 22 분 전
$AREC has a $99,873,419 market cap and are days away from merging with $CGRA. $CGRA is sitting at $.0049 with a market cap of $3,476,070 up 48.48% today closing near the high of day. The last merger $CGRA had, the share price went to $.162. This merger with $AREC is much bigger... Peeps will figure
AREC CGRA
pepeoil pepeoil 24 분 전
Cohen doesn’t pay but it’s a frivolous lawsuit? Bwahaaaaaa

They say old Joshy put the receivables he sold into a different account so they couldn’t get them. Bwahaaaa

The old slick joshy. That’s your CEO. LOL

https://iapps.courts.state.ny.us/n
AZRH
BluePuppet BluePuppet 27 분 전
Expert Market, nice
SFLM
BluePuppet BluePuppet 27 분 전
Expert market, nice
GSTC
AlbertoBe AlbertoBe 27 분 전
Hi IBB-99,

That are the results of Q4-24, very curious how Q1-25 will look like…

Do you think the institutions are keeping their shares? That would be a very good sign!

AlbertoBe
LWLG
pepeoil pepeoil 36 분 전
Oh, here is another judgement. Bwahaaaa for over $45,675. Oops. He just doesn’t pay . Lol

https://iapps.courts.state.ny.us/nyscef/ViewDocument?docIndex=OS_PLUS_Rgz5UXf3WGTPSe7G6kQ==
AZRH
pepeoil pepeoil 38 분 전
Old cohen lied again. There were 2 cash advances, not one for $12,000 that turned into $87,000 judgment. One was for $51,217.95. Oops , he forgot that one. Lol. Both were guaranteed by him. lol. Oops, he forgot that part too. But he know everything, he just forgets . Bwahaaa
AZRH
cottonisking cottonisking 40 분 전
LBHI's Cts' successor rights are good. AI Lehman Brothers likely included a successor clause in its 2024 amended framework agreement to ensure the continued validity and enforceability of the agreement even if the company's ownership structure or legal entity changes. This is a common practice in ag
LEHNQ
PegnVA PegnVA 42 분 전
Excellent!...Can the Dem party borrow him for a few months?!
Investor2014 Investor2014 43 분 전
One thing to keep in mind here is that in the P2b/3 trial about 70% of patients were on concomitant Donepezil with A2-73 or placebo. If we assume even distribution between placebo and dose arms then comparing to Donepezil only trial results should in principle show the differential effect of A2-73.
AVXL
sam1933 sam1933 51 분 전
$HBAR Price Prediction Post Its ETF Approval

Per ChatGPT, Hedera (HBAR) could surge as high as $0.60 in a short-term scenario (1-2 weeks post the approval).

At the same time, the mid-term scenario includes HBAR surging as high as $0.75. This may happen when institution
HBAR
sam1933 sam1933 51 분 전
$HBAR Price Prediction Post Its ETF Approval

Per ChatGPT, Hedera (HBAR) could surge as high as $0.60 in a short-term scenario (1-2 weeks post the approval).

At the same time, the mid-term scenario includes HBAR surging as high as $0.75. This may happen when institution
HBAR
molee molee 54 분 전
WHERE is the filing ????? https://www.otcmarkets.com/stock/NAFS/disclosure .
NAFS
janice shell janice shell 55 분 전
Sure we do, and I'd be the first to say so. But that doesn't and shouldn't mean we shove our elders in a closet and pretend they don't exist. Joe's not perfect, but I think after a very long life of service to his country and party, he's been treated pretty shabbily since sometime last summer.
nwtf nwtf 59 분 전
You need to come to the realization that ERHE doesnt have any rights anymore. You post doesnt mean squat.
ERHE
PegnVA PegnVA 1 시간 전
As I said, the message was spot on - the messenger wasn't the best...Joe's days are in the past, and I'm not sure he realizes it yet.
The Dems need younger messengers, both male and female, who can communicate new ideas effectively.
nwtf nwtf 1 시간 전
Then he needs to be an adult. If he doesnt like it then dont come here. But he must realize that if he keeps telling lies he deserves what he gets.
ERHE
sentiment_stocks sentiment_stocks 1 시간 전
I do so love to read your posts. :)
NWBO
janice shell janice shell 1 시간 전
Brilliant job by Elizabeth Warren, who found herself on CNBC, dealing with an idiot:

https://bsky.app/profile/atrupar.com/post/3lmzuzydlhs2p

최근 히스토리

NASDAQ
NAYA
NAYA Biosciences
Delayed Upgrade Clock
ADVFN Logo
대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2025 ADVFN PLC - 모든 권리 보유

광고 제거

광고 없는 경험을 위해 가입하세요

광고 없음

지금 사용해 보세요

광고 유지